Completed NA INTERVENTIONAL 2-arm NCT04606407

Inhaled NO for the Treatment of Viral Pneumonia in Adults

Prospective, Open-label, Randomized, Multi-Center Study for Safety and Efficacy Evaluation of Inhaled Nitric Oxide (NO) Given Intermittently to Adults With Viral Pneumonia

Sponsor: Beyond Air Inc.

Conditions Covid19 Inhaled Nitric Oxide Nitric Oxide Pneumonia, Viral Respiratory Disease SARS-CoV Infection Viral Pneumonia

Interventions LungFit™

Updated 6 times since 2020 Last updated: Dec 14, 2022 Started: Nov 25, 2020 Primary completion: Aug 7, 2022 Completion: Aug 7, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Covid19 and Inhaled Nitric Oxide and is currently completed. Beyond Air Inc. leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2022 — Jan 2023 [monthly]

Recruiting NA
Jan 2021 — Feb 2022 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Nov 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beyond Air Inc.

Data source: Beyond Air Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel
• Petah Tikva, Israel